Skip to main content
Journal ArticleOPEN ACCESS

Is Long-acting Cabotegravir a Pre-exposure Prophylaxis Option for Women of Childbearing Potential?

Open Forum Infectious Diseases (2022) 9(7)
DOI: 10.1093/ofid/ofac230
4Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Long-acting cabotegravir (CAB-LA) provides an exciting new option for pre-exposure prophylaxis (PrEP) in multiple populations. In this Perspective, we consider the unique pharmacokinetics of CAB-LA and the potential impact on the prescribing of CAB-LA, specifically in cis-women of reproductive potential.

Author supplied keywords

References Powered by Scopus

Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

The Lancet
309Citations
N/AReaders
Get full text

Formulation and pharmacology of long-acting cabotegravir

Current Opinion in HIV and AIDS
151Citations
N/AReaders
Get full text

Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study

The Lancet Global Health
132Citations
N/AReaders
Get full text
View more at Scopus

Cited by Powered by Scopus

The experience of healthcare workers to HIV pre-exposure prophylaxis (PrEP) implementation in low- and middle-income countries: a systematic review and qualitative meta-synthesis

Frontiers in Public Health
3Citations
N/AReaders
Get full text

HIV Pre-Exposure Prophylaxis

Infectious Disease Clinics of North America
2Citations
N/AReaders
Get full text

Knowledge domain and emerging trends in HIV pre-exposure prophylaxis: A visualization analysis via CiteSpace

Frontiers in Microbiology
2Citations
N/AReaders
Get full text
View more at Scopus

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Sahloff, E. G., Hamons, N., Baumgartner, K., & Duggan, J. M. (2022). Is Long-acting Cabotegravir a Pre-exposure Prophylaxis Option for Women of Childbearing Potential? Open Forum Infectious Diseases, 9(7). https://doi.org/10.1093/ofid/ofac230

Readers' Seniority

Tooltip

Researcher 1

100%

Readers' Discipline

Tooltip

Medicine and Dentistry 2

100%

Save time finding and organizing research with Mendeley

Sign up for free